About: Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.83 (-1.02%)
SVRA NASDAQ Savara Inc
Loading watchlist status…
Savara Inc share price
SVRA price activity
Last Price
$4.830
Change (24hr)
-0.05 USD (-1.02%)
Volume
2.44M
Volume (4w avg)
-
Open
$4.85
Day Range
$4.64 - $4.92
Previous Close
$4.88
Last Trade
08 Oct, 8:00 pm GMT+0
Delayed
08 Oct, 8:00 pm GMT+0
SVRA price performance
0.42%
5D
-12.66%
1M
-19.9%
YTD
39.19%
1Y
Delayed
08 Oct, 8:00 pm GMT+0
SVRA Market Signals